DIALECTIC THERAPEUTICS
Dialectic Therapeutics (DT) is a pre-clinical biotechnology company dedicated to the development of unique, impactful anti-cancer drugs that effectively treat patients with few to no other options. The company's drugs selectively induce cancer cells to degrade B-cell lymphoma and stimulate the cells to commit suicide or become susceptible to chemotherapy, enabling patients to have increased disease-free survival. Dialectic Therapeutics was founded in 2018 and is located in Dallas, Texas.
DIALECTIC THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.dtsciences.com
Total Employee:
1+
Status:
Active
Contact:
972.888.8179
Email Addresses:
[email protected]
Total Funding:
19.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Office 365 Mail ReCAPTCHA
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Dialectic Therapeutics
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Dialectic Therapeutics
Official Site Inspections
http://www.dtsciences.com Semrush global rank: 5.76 M Semrush visits lastest month: 1.45 K
- Host name: 66.175.239.102
- IP address: 66.175.239.102
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Dialectic Therapeutics"
Dialectic
DIALECTIC’S LEAD CANDIDATE, DT2216, is a novel Antiapoptotic Protein Targeted Degradation (APTaDâ„¢) compound that selectively induces cancer cells to degrade B-cell …See details»
Dialectic Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 972.888.8179 Dialectic Therapeutics (DT) is a pre-clinical biotechnology company dedicated to the development of unique, impactful anti …See details»
Dialectic Therapeutics Inc - LinkedIn
Dialectic is a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat cancer. Our goal is to relieve the suffering of patients with cancer …See details»
Dialectic Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.dtsciences.com. Startups | Private Company | 2018 | Texas, United States | < 10 | www.dtsciences.com. Last update 08 May 2025. Overview. Pipeline. Deal. Translational …See details»
Dialectic Therapeutics Company Profile | Management and
Www.dtsciences.com Dialectic Therapeutics Profile and History Dialectic Therapeutics is a biotechnology company dedicated to the development of innovative anti-cancer drugs, …See details»
Dialectic Therapeutics Receives $14.4 Million Texas Company …
DALLAS, Aug. 20, 2021 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic ®), a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat ...See details»
Orphanet: DIALECTIC THERAPEUTICS, INC.
E-mail: [email protected]. Dialectic Therapeutics, Inc. Dialectic Therapeutics, Inc. 3889 Maple Ave - STE 125 75219 DALLAS TX UNITED STATES. Contact email: [email protected]. …See details»
Dialectic Therapeutics Receives $3 Million Seed Award for Product ...
DALLAS, Feb. 26, 2020 /PRNewswire/ -- Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to end cancer, today …See details»
Dialectic Therapeutics - PitchBook
Dialectic Therapeutics General Information Description. Operator of a biotechnology company intended to create new technologies to treat cancer. The company's drugs specialize in …See details»
Dialectic Therapeutics - Overview, News & Similar companies
Aug 19, 2021 Dialectic Therapeutics contact info: Phone number: (972) 525-1499 Website: www.dtsciences.com What does Dialectic Therapeutics do? Dialectic is a Texas-based clinical …See details»
Dialectic Therapeutics - News, Partnerships, Locations and …
Usearch identified 1 signals for Dialectic Therapeutics, including: 1 Partnerships. Usearch discovered 1 location for Dialectic Therapeutics including locations in Dallas · Texas. Dialectic …See details»
Dialectic Therapeutics - VentureRadar
"Dialectic Therapeutics (DT) is a pre-clinical biotechnology company dedicated to the development of unique, impactful anti-cancer drugs that effectively treat patients with few to no …See details»
Dialectic Therapeutics Announces DT2216 Has Received Orphan …
DALLAS, March 14, 2022 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic ®), a Texas-based clinical stage biotechnology company focused on creating innovative new technologies …See details»
The Fibrolamellar Cancer Foundation establishes partnership with ...
Apr 21, 2025 FCF, a public 501(c)(3) nonprofit organization based in Greenwich, CT, was founded in 2009. Today, FCF is the leading non-governmental funder of FLC research. By …See details»
Dialectic Therapeutics - VentureRadar
Website: https://www.dtsciences.com/ Develops novel anti-cancer drugs targeting patients with limited options, focusing on Antiapoptotic Protein Targeted Degradation ...See details»
Dialectic Therapeutics Receives FDA Clearance of IND ... - BioSpace
DALLAS, March 3, 2021 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic ®), a Texas-based biotechnology company focused on creating innovative new technologies to treat …See details»
Dialectic Therapeutics Receives $3 Million Seed Award for Product ...
Feb 26, 2020 For more information regarding Dialectic Therapeutics, please visit www.dtsciences.com. About the Cancer Prevention Research Institute of Texas To date, ...See details»
Dialectic Therapeutics Receives FDA Clearance of IND Application …
Mar 3, 2021 Dialectic Therapeutics Receives FDA Clearance of IND Application for Lead Antiapoptotic Protein Targeted Degradation (APTaD) Candidate DT2216See details»
Dialectic Therapeutics Announces First-in-Human Dose in
Oct 6, 2021 Dialectic Therapeutics, Inc. (Dialectic®), a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat cancer, today announced …See details»
Dialectic Therapeutics Announces DT2216 Has Received Orphan …
DALLAS, March 14, 2022 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic ®), a Texas-based clinical stage biotechnology company focused on creating innovative new technologies …See details»